Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
ACS Nano. 2012 Oct 23;6(10):8620-31. doi: 10.1021/nn301975s. Epub 2012 Aug 27.
Tumor-targeted delivery of siRNA remains a major barrier in fully realizing the therapeutic potential of RNA interference. While cell-penetrating peptides (CPP) are promising siRNA carrier candidates, they are universal internalizers that lack cell-type specificity. Herein, we design and screen a library of tandem tumor-targeting and cell-penetrating peptides that condense siRNA into stable nanocomplexes for cell type-specific siRNA delivery. Through physiochemical and biological characterization, we identify a subset of the nanocomplex library of that are taken up by cells via endocytosis, trigger endosomal escape and unpacking of the carrier, and ultimately deliver siRNA to the cytosol in a receptor-specific fashion. To better understand the structure-activity relationships that govern receptor-specific siRNA delivery, we employ computational regression analysis and identify a set of key convergent structural properties, namely the valence of the targeting ligand and the charge of the peptide, that help transform ubiquitously internalizing cell-penetrating peptides into cell type-specific siRNA delivery systems.
肿瘤靶向递送达 RNA 干扰的治疗潜力仍存在重大障碍。虽然细胞穿透肽(CPP)是很有前途的 siRNA 载体候选物,但它们是普遍的内吞体,缺乏细胞类型特异性。在此,我们设计和筛选了一系列串联的肿瘤靶向和细胞穿透肽文库,可将 siRNA 浓缩成稳定的纳米复合物,用于细胞类型特异性 siRNA 递送。通过理化和生物学特性分析,我们确定了纳米复合物文库中的一小部分可通过内吞作用被细胞摄取,触发内涵体逃逸和载体解包,并最终以受体特异性方式将 siRNA 递送至细胞质。为了更好地理解控制受体特异性 siRNA 递送的结构-活性关系,我们采用计算回归分析,并确定了一组关键的收敛结构特性,即靶向配体的价数和肽的电荷,这有助于将普遍内吞的细胞穿透肽转化为细胞类型特异性 siRNA 递送系统。